These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9402787)

  • 41. Cancer survival among women.
    Stat Bull Metropol Life Insur Co; 1977 Oct; 58():7-9. PubMed ID: 929634
    [No Abstract]   [Full Text] [Related]  

  • 42. [Basic tasks of the statistical analysis of data on the survival of cancer patients].
    Kadyrova NO; Antipova TV; Zherbin EA; Iakovlev AIu
    Vopr Onkol; 1984; 30(7):24-32. PubMed ID: 6464399
    [No Abstract]   [Full Text] [Related]  

  • 43. Fraction of normal remaining life span: a new method for expressing survival in cancer.
    Vaidya JS; Mittra I
    BMJ; 1997 Jun; 314(7095):1682-4. PubMed ID: 9193295
    [No Abstract]   [Full Text] [Related]  

  • 44. [Early detection of malignant neoplasms and the life expectancy of patients].
    Dvoĭrin VV; Aksel' EM
    Sov Zdravookhr; 1984; (4):30-4. PubMed ID: 6729576
    [No Abstract]   [Full Text] [Related]  

  • 45. [A new family of distributions for the parametric analysis of data on the life expectancy of tumor carriers].
    Kamynina TV; Iakovlev AIu; Anisimov VN; Zhukovskaia NV
    Vopr Onkol; 1987; 33(6):23-8. PubMed ID: 3617597
    [No Abstract]   [Full Text] [Related]  

  • 46. New method of expressing survival in cancer is popular.
    Vaidya JS; Mittra I
    BMJ; 1998 Apr; 316(7137):1092. PubMed ID: 9552922
    [No Abstract]   [Full Text] [Related]  

  • 47. Survival quotient as a method for investigating psychosocial aspects of cancer survival.
    Worden JW; Johnston LC; Harrison RH
    Psychol Rep; 1974 Oct; 35(2):719-26. PubMed ID: 4438522
    [No Abstract]   [Full Text] [Related]  

  • 48. [Letter: Cancer and life insurance].
    Lampe CE; Mortensen V
    Ugeskr Laeger; 1974 Apr; 136(18):986-7. PubMed ID: 4840098
    [No Abstract]   [Full Text] [Related]  

  • 49. Cancer in Scotland.
    Kemp IW; Ruthven HE
    Health Bull (Edinb); 1978 May; 36(3):105-10. PubMed ID: 659097
    [No Abstract]   [Full Text] [Related]  

  • 50. The random introduction of patients into a clinical trial: various aspects of estimates and probabilities of survival.
    Tallis GM; Sarfaty G; Leppard P
    Comput Biomed Res; 1977 Jun; 10(3):205-12. PubMed ID: 326473
    [No Abstract]   [Full Text] [Related]  

  • 51. Challenges in design and interpretation of observational research on health behaviors and cancer survival.
    Ballard-Barbash R; Neuhouser ML
    JAMA; 2009 Dec; 302(22):2483-4. PubMed ID: 19996407
    [No Abstract]   [Full Text] [Related]  

  • 52. [Principles of calculation of survival time in malignant neoplasms].
    Pawlega J; Kołodziejska H
    Nowotwory; 1981; 30(4):337-45. PubMed ID: 7279688
    [No Abstract]   [Full Text] [Related]  

  • 53. Cancer survival is no lottery.
    Ozonoff D; Clapp R
    Lancet; 1999 Apr; 353(9162):1379-80. PubMed ID: 10227215
    [No Abstract]   [Full Text] [Related]  

  • 54. Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.
    Petelin L; Liew D; Mitchell G; James PA; Trainer AH
    Value Health; 2018 Jul; 21(7):891-893. PubMed ID: 30005762
    [No Abstract]   [Full Text] [Related]  

  • 55. Analysis of survival by tumor response: have we learnt any better?
    Ihorst G; Waldschmidt J; Schumacher M; Wäsch R; Engelhardt M
    Ann Hematol; 2015 Sep; 94(9):1615-6. PubMed ID: 26099841
    [No Abstract]   [Full Text] [Related]  

  • 56. Giving is the Key to Survival.
    Harari VE
    Pract Radiat Oncol; 2019 Nov; 9(6):e484. PubMed ID: 31002884
    [No Abstract]   [Full Text] [Related]  

  • 57. Cancer survival: [corrected] the CONCORD-2 study.
    Freitas-Junior R; Soares LR; Barrios CH
    Lancet; 2015 Aug; 386(9992):428-9. PubMed ID: 26251386
    [No Abstract]   [Full Text] [Related]  

  • 58. New method for expressing survival in cancer. Use of age specific relative survival is sufficient.
    Cresswell J
    BMJ; 1997 Nov; 315(7119):1376. PubMed ID: 9402787
    [No Abstract]   [Full Text] [Related]  

  • 59. New method for expressing survival in cancer. New method would be more meaningful to patients than 10 year survival rates.
    Harrison J
    BMJ; 1997 Nov; 315(7119):1375. PubMed ID: 9402785
    [No Abstract]   [Full Text] [Related]  

  • 60. New method for expressing survival in cancer. Relation between survival times and patients' age at diagnosis must be taken into account.
    Marubini E; Mariani L
    BMJ; 1997 Nov; 315(7119):1375-6. PubMed ID: 9402786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.